When Orit Markowitz, MD, embarked on her dermatology career years ago, there were limited – if any — treatments available for advanced melanoma. However, thanks to innovative thinking and the relentless dedication of researchers, there’s been a significant expansion in options for melanoma patients. Dr. Markowitz highlighted an exciting development for oncologists—a noteworthy trial has …
Dermcast.live host Hope Cook, PA-C, engages Dr. Stephen Tyring in an interesting conversation about dermatological conditions for which off-label use of medications are helpful (e.g., warts and autoimmune blistering diseases). Dr. Tyring also guides listeners through situations in which off-label use is the only reasonable choice (e.g., no on-label medications exist, insurance does not cover …
SDPA Summer Conference Medical Director Travis Vandergriff, MD, reviewed the epidemiology of melanoma in a lecture focused on melanoma and non-melanoma in U.S. patients. Melanoma is the fifth most diagnosed cancer in people in the US with the highest incidence among non-Hispanic white males and the lowest incidence among black women. A review of data …
Long time SDPA favorite, Ted Rosen, MD, highlighted timely, intriguing and important updates found within the medical literature for 2022 in a presentation at the SDPA Annual Summer Dermatology Conference in Austin, Texas. He initiated the talk reviewing an article out of Sweden where patients report they are not receiving enough information from their physicians …